NAGE vs TECH · P/E 59, rev $99.6M vs P/E 65, rev $1.22B
Niagen Bioscience, Inc. (NAGE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NAGE and TECH stock pages for the full models.
Not investment advice.